Body composition and muscle strength are emerging aspects in idiopathic pulmonary
fibrosis (IPF) clinical assessment. We aimed to study the relationships of handgrip strength …

This study aimed to examine the validity of urinary N-terminal titin fragment/creatinine
(urinary N-titin/Cr) reflecting muscle damage biomarker in patients with interstitial lung …

Background Computed tomography (CT) is commonly utilized in chronic obstructive
pulmonary disease (COPD) for lung cancer screening and emphysema characterization …

Background Pleuroparenchymal fibroelastosis (PPFE) is a rare interstitial lung disease (ILD)
featuring dense fibrosis of the visceral pleura and subpleural parenchyma, mostly in the …

Background The assessment of lung physiology via pulmonary function tests (PFTs) is
essential for patients with idiopathic pulmonary fibrosis (IPF). However, PFTs require active …

Idiopathic pulmonary fibrosis (IPF), an incurable lung disease of unknown cause, often
presents with losses of skeletal muscle mass. IPF requires comprehensive care, but it has …

Antifibrotic therapy (AFT) slows disease progression in patients with idiopathic pulmonary
fibrosis (IPF). The Gender-Age-Physiology (GAP) index, was developed based on data at …

Background Idiopathic pleuroparenchymal fibroelastosis (iPPFE), a progressive fibrotic
disease, is characterised by upper lobe–dominant lung fibrosis involving the pleura and …

Background Mycobacterium avium complex (MAC) causes chronic respiratory infectious
diseases with diverse clinical features and prognoses. Pleuroparenchymal fibroelastosis …

Adipose tissue has functions beyond its principal functions in energy storage, including
endocrine and immune functions. When faced with a surplus of energy, the functions of …